TNBCs had a high expression of SphK1 and promoted lung metastasis while blocking expression produced the opposite effect. FSCN1, a contributor to metastasis, was found to be upregulated by SphK1 through the activation of NFkB. By inhibiting the pathway, tumor growth and lung metastasis were inhibited as well. Here, SPHK1 is linked to neoplasm.